Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1819-1823

  Yu, Yun Zhou ^a   Li, Na ^a   Wang, Rui Lin ^a   Zhu, Heng Qi ^a   Wang, Shuang ^a   Yu, Wei Yuan ^a   Sun, Zhi Wei ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BOTULINUM TOXIN F; FHC PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2A; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BACTERIAL GENE; BOTULISM; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FHC GENE; IMMUNIZATION; LD 50; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REPEATED DRUG DOSE; SEROTYPE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; BASE SEQUENCE; BOTULINUM TOXINS; BOTULISM; CLONING, MOLECULAR; CLOSTRIDIUM BOTULINUM TYPE F; FEMALE; GENES, SYNTHETIC; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 57349187881     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00239-08     Document Type: Article

References (23)

1. Baldwin, M. R., W. H. Tepp, C. L. Pier, M. Bradshaw, M. Ho, B. A. Wilson, R. B. Fritz, E. A. Johnson, and J. T. Barbieri. 2005. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infect. Immun. 73:6998-7005.
2. Baldwin, M. R., W. H. Tepp, A. Przedpelski1, C. L. Pier, M. Bradshaw, E. A. Johnson, and J. T. Barbieri. 2008. A subunit vaccine against the seven serotypes of botulism. Infect. Immun. 76:1314-1318.
3. Bennett, A. M., S. D. Perkins, and J. L. Holley. 2003. DNA vaccination protects against botulinum neurotoxin type F. Vaccine 21:3110-3117.
4. Brown, A. T., A. R. Gregory, T. M. Ellis, and M. N. Hearnded. 1999. Comparative immunogenicity of two bivalent botulinum vaccines. Aust. Vet. J. 77:388-391.
5. Brunger, A. T., M. A. Breidenbach, R. Jin, A. Fischer, J. S. Santos, and M. Montal. 2007. Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain. PLOS Pathog. 3:1191-1194.
6. Byrne, M. P., and L. A. Smith. 2000. Development of vaccines for prevention of botulism. Biochimie 82:955-966.
7. Byrne, M. P., T. J. Smith, V. A. Montgomery, and L. A. Smith. 1998. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate. Infect. Immun. 66:4817-4822.
8. Byrne, M. F., R. W. Titball, J. Holley, and L. A. Smith. 2000. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris. Protein Expr. Purif. 18:327-337.
9. Clayton, M. A., J. M. Clayton, D. R. Brown, and J. L. Middlebrook. 1995. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli. Infect. Immun. 63:2728-2742.
10. Holley, J. L., M. Elmore, M. Mauchline, N. Minton, and R. W. Titball. 2001. Cloning, expression, and evaluation sub-unit vaccine against clostridium type F toxin. Vaccine 19:288-297.
11. Jathoul, A. P., J. L. Holley, and H. S. Garmory. 2004. Efficacy DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters. Vaccine 22:3942-3946.
12. Johnson, S. K., W. Zhang, L. A. Smith, K. J. Hywood-Potter, S. T. Swanson, V. L. Schlegel, and M. M. Meagher. 2003. Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastoris. Protein Expr. Purif. 32:1-9.
13. LaPenotiere, H. F., M. A. Clayton, and J. L. Middlebrook. 1995. Expression of a large nontoxic fragment of botulinum neurotoxin serotype A and its use as an immunogen. Toxicon 33:1383-1386.
14. Middlebrook, J. L. 2005. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv. Drug Deliv. Rev. 57:1415-11423.
15. Ravichandran, E., F. H. Al-Saleem, D. M. Ancharski, M. D. Elias, A. K. Singh, M. Shamim, Y. Gong, and L. L. Simpson. 2007. Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect. Immun. 75:3043-3054.
16. Romanos, M. A., A. J. Makoff, N. F. Fairweather, K. M. Beesley, D. E. Slater, F. B. Rayment, M. M. Payne, and J. J. Clare. 1991. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucleic Acids Res. 19:1461-1467.
17. Schiavo, G., M. Matteoli, and C. Montecucco. 2000. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80:717-766.
18. Smith, L. A. 1998. Development of recombinant vaccines for botulinum neurotoxin. Toxicon 36:1539-1548.
19. Tavallaie, M., A. Chenal, D. Gillet, Y. Pereira, M. Manich, M. Gibert, S. Raffestin, M. R. Popoff, and J. C. Marvaud. 2004. Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett. 572:299-306.
20. Turton, K., J. A. Chaddock, and K. R. Acharya. 2002. Botulinum and tetanus neurotoxtins: structure, function and therapeutic utility. Trends Biochem. Sci. 27:552-558.
21. Woodward, L. A., H. Arimitsu, R. Hirst, and K. Oguma. 2003. Expression of Hc subunits from Clostridium botulinum type C and D and their evaluation as candidate vaccine antigens in mice. Infect. Immun. 71:2941-2944.
22. Yu, Y. Z., Z. W. Sun, S. Wang, and W. Y. Yu. 2007. High-level expression of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli and its immunogenicity as an antigen. Chin. J. Biotechnol. 23:812-817.
23. Yu, Y. Z., S. M. Zhang, Z. W. Sun, S. Wang, and W. Y. Yu. 2007. Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A. Vaccine 25:8843-8850.